80 related articles for article (PubMed ID: 29454962)
1. The high bone mass phenotype of Lrp5-mutant mice is not affected by megakaryocyte depletion.
Yorgan T; David JP; Amling M; Schinke T
Biochem Biophys Res Commun; 2018 Mar; 497(2):659-666. PubMed ID: 29454962
[TBL] [Abstract][Full Text] [Related]
2. The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.
Yorgan TA; Peters S; Jeschke A; Benisch P; Jakob F; Amling M; Schinke T
J Bone Miner Res; 2015 Jul; 30(7):1175-83. PubMed ID: 25640331
[TBL] [Abstract][Full Text] [Related]
3. Mice rendered severely deficient in megakaryocytes through targeted gene deletion of the thrombopoietin receptor c-Mpl have a normal skeletal phenotype.
Perry MJ; Redding KA; Alexander WS; Tobias JH
Calcif Tissue Int; 2007 Sep; 81(3):224-31. PubMed ID: 17674074
[TBL] [Abstract][Full Text] [Related]
4. High bone mass in mice expressing a mutant LRP5 gene.
Babij P; Zhao W; Small C; Kharode Y; Yaworsky PJ; Bouxsein ML; Reddy PS; Bodine PV; Robinson JA; Bhat B; Marzolf J; Moran RA; Bex F
J Bone Miner Res; 2003 Jun; 18(6):960-74. PubMed ID: 12817748
[TBL] [Abstract][Full Text] [Related]
5. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.
Meijome TE; Ekwealor JTB; Hooker RA; Cheng YH; Ciovacco WA; Balamohan SM; Srinivasan TL; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2016 Apr; 117(4):959-69. PubMed ID: 26375403
[TBL] [Abstract][Full Text] [Related]
6. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
Mintern J; Williams N; Jackson H
Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
[TBL] [Abstract][Full Text] [Related]
7. Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.
Galán-Díez M; Isa A; Ponzetti M; Nielsen MF; Kassem M; Kousteni S
Biochim Biophys Acta; 2016 Mar; 1863(3):490-498. PubMed ID: 26681532
[TBL] [Abstract][Full Text] [Related]
8. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
9. Novel familial mutation of LRP5 causing high bone mass: Genetic analysis, clinical presentation, and characterization of bone matrix mineralization.
Roetzer KM; Uyanik G; Brehm A; Zwerina J; Zandieh S; Czech T; Roschger P; Misof BM; Klaushofer K
Bone; 2018 Feb; 107():154-160. PubMed ID: 29208525
[TBL] [Abstract][Full Text] [Related]
10. An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance.
Chan ER; Lavender H; Li G; Haviernik P; Bunting KD; Adams MD
Exp Hematol; 2009 Feb; 37(2):276-84. PubMed ID: 19059699
[TBL] [Abstract][Full Text] [Related]
11. The LRP5 high-bone-mass mutation causes alveolar bone accrual with minor craniofacial alteration.
Turkkahraman H; Flanagan S; Zhu T; Bellido TM; Yuan X
J Periodontal Res; 2023 Aug; 58(4):723-732. PubMed ID: 37128744
[TBL] [Abstract][Full Text] [Related]
12. Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia.
Niziolek PJ; Bullock W; Warman ML; Robling AG
PLoS One; 2015; 10(11):e0140775. PubMed ID: 26554834
[TBL] [Abstract][Full Text] [Related]
13. Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice.
Kauppi M; Murphy JM; de Graaf CA; Hyland CD; Greig KT; Metcalf D; Hilton AA; Nicola NA; Kile BT; Hilton DJ; Alexander WS
Blood; 2008 Oct; 112(8):3148-53. PubMed ID: 18684867
[TBL] [Abstract][Full Text] [Related]
14. A mutagenesis-derived
Charette JR; Earp SE; Bell BA; Ackert-Bicknell CL; Godfrey DA; Rao S; Anand-Apte B; Nishina PM; Peachey NS
Mol Vis; 2017; 23():140-148. PubMed ID: 28356706
[TBL] [Abstract][Full Text] [Related]
15. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of low-density lipoprotein receptor-related protein 5 increases cartilage degradation in instability-induced osteoarthritis.
Lodewyckx L; Luyten FP; Lories RJ
Rheumatology (Oxford); 2012 Nov; 51(11):1973-8. PubMed ID: 22850184
[TBL] [Abstract][Full Text] [Related]
17. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
18. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.
Lee GS; Simpson C; Sun BH; Yao C; Foer D; Sullivan B; Matthes S; Alenina N; Belsky J; Bader M; Insogna KL
J Bone Miner Res; 2014 Apr; 29(4):976-81. PubMed ID: 24038240
[TBL] [Abstract][Full Text] [Related]
19. Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice.
Ma D; Li Y; Hackfort B; Zhao Y; Xiao J; Swanson PC; Lappe J; Xiao P; Cullen D; Akhter M; Recker R; Xiao GG
J Proteome Res; 2012 Jul; 11(7):3548-60. PubMed ID: 22616666
[TBL] [Abstract][Full Text] [Related]
20. The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation.
Wang X; Zhang H; Hu L; He J; Jiang Q; Ren L; Yu K; Fu M; Li Z; He Z; Zhu J; Wang Y; Jiang Z; Yang G
Bone; 2024 Jun; ():117172. PubMed ID: 38909879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
